Several months after finding himself in the middle of a boardroom ruckus, Phillip Frost plans to step down as chairman of Teva Pharmaceuticals by the end of the year, according to a filing with the U.S. Securities and Exchange Commission. A replacement has not been chosen.. His pending departure is not a surprise, given that he signaled his intent to resign earlier this year. But the circumstances leading the 77-year-old to make this decision were tumultuous.